For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit

Congratulations! Second R01 from the NIH Awarded to Dr. Anna Orr’s team

Dr. Orr and her team will investigate novel roles of mitochondria in neural signaling and discover new treatment approaches for aging-related disorders of the brain.

Mitochondria are organelles that produce energy and participate in normal intracellular signaling. However, they also release free radicals that can impair neural cells and promote disorders of the brain. The main contributing factors in dementia, including aging and proteinopathy, are linked to mitochondrial dysfunction and accumulation of free radicals. Recent evidence suggests that mitochondrial free radicals act as central drivers of diverse pathogenic processes in dementia. Dr. Orr’s team will investigate the precise roles of mitochondrial free radicals in dementia-linked pathology and new candidate mechanisms underlying the effects of free radicals on neural cells. These studies are expected to uncover new therapeutic approaches and mechanistic insights into brain impairments associated with dementia.

Weill Cornell Medicine Helen & Robert Appel Alzheimer’s Disease Research Institute 413 E. 69th St. New York, NY 10021